| |
|
|
|
Immune Pharmaceuticals Inc.  
|
|
0.1896 -0.003 (-0.02%) |
06-22 15:58 |
|
Open: |
0.1995 |
Pre close: |
0.1931 |
Target:
|
0.28 
|
|
High: |
0.1995 |
Low: |
0.18 |
Resistance:
|
0.24
0.27
|
|
Volume: |
706,942 |
Market Cap: |
6M |
Support:
|
0.18
0.15
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.20
|
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
0.22 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.34 |
Stochastic Oscillator |
%K(14,3):
|
3.56  |
|
MA(250): |
0.91 |
%D(3): |
1.19 |
|
Average Volume(K) |
3-Month: |
59638
|
52-Week |
High:
|
3.43 |
|
10-Days: |
89183 |
Low: |
0.18 |
|
RSI |
RSI(14):
|
26.83 |
Change(%): |
-93.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-370.4 |
Shares Out. (M) |
32.00 |
|
EPS Est. Current Year |
-0.620 |
Return on Assets (ttm) |
-109.9 |
Shares Float (M) |
23.86 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.20 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
924 |
|
Book Value (p.s.) |
0.790 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.24 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.36 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.96 |
P/CF |
-0.49 |
|
|
|
|
|
|
